Research And Markets: Explore The New Directions Taken By Monoclonal Antibodies Concerning Technologies, Markets And Competition.

(PRWEB) October 20, 2004 -- Research and Markets announces the addition of 'New Directions in Monoclonal Antibodies: Technologies, Markets, Competition to their offering.

The monoclonal antibody market has experienced explosive growth in the nearly 30 years since the process for creating mAbs was introduced. More than fifteen therapeutic mAbs have been approved, several of which have reached blockbuster status

New Directions in Monoclonal Antibodies: Technologies, Markets, Competition reviews the broad drug development effort that is focused on bringing improved mAb-based products to the market, including those used for drug discovery research, in vivo diagnostics, and therapeutic applications.

Numerous diagnostic mAbs have also been approved, making this one of the fastest growing fields in biotechnology. Today, the industry is working as furiously as ever to perfect the design and production of mAbs for therapeutic, diagnostic, and other purposes. This report evaluates the salient issues in these endeavours.

New Directions in Monoclonal Antibodies examines the more than 110 mAb products currently in clinical trials, as well as the products that are already available and those still at the preclinical stage that are likely to play an important role in the advancement of the field.

The report presents further analysis to evaluate the market potential for monoclonal antibodies in development for a variety of diseases. It reviews some general observations concerning commercialization of mAbs, then addresses the major disease categories, including patient numbers for diseases of interest; competing therapeutics already on the market, particularly those that have recently gained regulatory approval; and, where available, estimates of market sizes in dollars. Only those conditions for which drug candidates have been identified or which have been prominently mentioned as potential markets by pharmaceutical companies in the field are covered

For a complete index of this report click on http://www.researchandmarkets.com/reports/225276

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com